China News Service, August 11. According to a report by Korea Radio International, as of 0:00 on the 11th, South Korea added 137,241 confirmed cases compared with the previous day, including 136,719 local infections and 522 imported cases.

At the same time, the number of critically ill cases and deaths continued to increase, and the speed and scale of the second infection accelerated.

  According to reports, the number of newly confirmed cases decreased by more than 14,000 from the previous day, but increased by more than 29,000 from a week ago.

The number of imported cases from abroad decreased by more than 90 from the previous day, but remained at a high of more than 450.

A medical worker guides people waiting to be tested for the new coronavirus at a makeshift testing site in Seoul, South Korea, on March 17, local time.

  The number of critically ill cases being hospitalized stood at 418, the highest since May 9 this year.

  There were 59 new deaths, the most since May 22.

From the perspective of the age group of the death cases, 80 years and above accounted for more than half, 33 cases; followed by 70-79 years old 11 cases, 60-69 years old 9 cases, 50-59 years old 4 cases, 20-29 years old 2 cases example.

  The number of second infections also continued to rise, jumping from more than 3,000 in the first week of last month to more than 28,000 in the fourth week, the report said.

The analysis shows that people aged 17 and below and unvaccinated people are the key groups of secondary infection.

In addition, based on the cases of the previous month, the time between the second infection and the first infection is an average of 5 months, which is more than 60 days shorter than the previous one.

  The epidemic prevention department called on high-risk groups to receive the fourth dose to prevent severe transformation and death.

South Korea's first domestic vaccine, SKYCovione produced by SK Biosciences, will be shipped as soon as the end of this month.

The vaccine will be used to vaccinate unvaccinated people.